KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Inventory Average (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Inventory Average readings, the most recent being $3.2 billion for Q1 2026.

  • On a quarterly basis, Inventory Average rose 1.61% to $3.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.2 billion, a 1.61% increase, with the full-year FY2025 number at $3.1 billion, down 11.98% from a year prior.
  • Inventory Average hit $3.2 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $3.3 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $4.1 billion in Q2 2023 to a low of $3.1 billion in Q1 2025.
  • Median Inventory Average over the past 5 years was $3.9 billion (2024), compared with a mean of $3.7 billion.
  • Biggest five-year swings in Inventory Average: rose 4.94% in 2023 and later dropped 21.53% in 2025.
  • Teva Pharmaceutical Industries' Inventory Average stood at $3.8 billion in 2022, then increased by 4.94% to $4.0 billion in 2023, then fell by 13.7% to $3.5 billion in 2024, then decreased by 6.66% to $3.3 billion in 2025, then dropped by 2.26% to $3.2 billion in 2026.
  • The last three reported values for Inventory Average were $3.2 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.4 billion (Q3 2025) per Business Quant data.